Back to search results

Visual Tools for Surgeon Decision-making in Prostate and Kidney Cancer

This study is looking at how visual tools can help cancer surgeons make decisions for patients with newly diagnosed localized prostate or kidney cancer. The study will involve surgeons viewing a visual decision support tool before talking with patients about their treatment options. Researchers want to see if using these visual tools changes how risks and benefits of surgery are discussed between doctors and patients. You can join if you are 18 or older and are willing to participate. The study aims to enroll 220 participants, and the current status is unclear.

Study design
This is an interventional study comparing patient encounters before and after surgeons use a visual decision support tool. It plans to enroll up to 20 surgeons and capture 200 patient visits.
What's involved
Your patient-doctor conversation will be audio recorded, and you will complete surveys about your communication with your doctor.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, discussion of risks and benefits, is measured at the baseline patient-physician encounter.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06965192

Designing Visual Tools to Enhance Cancer Surgeon Decision-making

Recruiting
NAAges 18+InterventionalSupportive care
UNC Lineberger Comprehensive Cancer Center
~220 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:VisualNo intervention

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Discussion of Risks and Benefits
Measured over Baseline (Patient-Physician Encounter)

Conditions

Prostate Cancer
Kidney Cancer

Explore related trials

Kidney CarcinomaProstate Carcinoma

Where it's being run

2 sites across 1 states
North Carolina2

Study leadership

  • Hung-Jui Tan, MD · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Deborah Usinger
[email protected]
(919) 962-5431
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Verbal informed consent was obtained to participate in the study.
Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
Age ≥ 18 years at the time of consent.
For patient subjects, HIPAA authorization for the release of personal health information and a new histologic diagnosis of localized prostate cancer based on prostate biopsy or clinical diagnosis of T1 renal mass (≤7 cm in diameter) Suspicion for kidney cancer based on cross-sectional imaging. New diagnosis is defined as within 6 months of consent. T1 renal masses include solid masses or Bosniak III/IV cystic masses.
For physician subjects, practicing urologist in North Carolina at UNC Health, Novant Health, or an affiliated site and sees patients with suspected or confirmed prostate or kidney cancer.

Exclusion

Non-English speaking.
Unwilling or unable to complete informed consent.
For patient subjects:

What this trial measures

  • Discussion of Risks and BenefitsBaseline (Patient-Physician Encounter)

    The impact of visual decision support on patient-physician communication will be assessed using coding-based thematic analysis of the debriefing interviews. The Informed Decision-Making coding system, which includes 9 elements which includes the nature of the clinical problem (e.g., cancer mortality risk, life expectancy), treatment options (e.g., surgery, alternatives), risks and benefits (e.g., complications, side effects, functional outcomes), and uncertainties (e.g., range of possible outcomes). Audio-recorded patient encounters will be coded. Paired coders will score these domains as a 0 (absent), 1 (partial, brief, or one-way), or 2 (complete, two-way discussion).